Farmax India Ltd

BSE: 590094 | NSE: FARMAXIND ISIN: INE890I01035
Market Cap: [Rs.Cr.] 5.34 Face Value: [Rs.] 1.00
Industry: Food - Processing - Indian

Watchlist +
Board Meet
  • 29-Aug-16

    • Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 29, 2016, inter alia, to consider and approved the following : 1. Draft Board Report for the Financial Year 2015-16; 2. Draft Notice to convene 21st Annual General Meeting of the Company for the Financial Year 2015-16. 3. Appointment of M/s S. Sarweswara Reddy & Associate, the Practicing Company Secretary, Hyderabad, as Secretarial Auditor for 2015-16. 4 .Appointment of M/s S. Sarweswara Reddy & Associate, the Practicing Company Secretary, Hyderabad, as a Scrutinizer for voting in 21st Annual General Meeting. Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2016, has considered & approved the following: 1. Draft Notice to convene 21st Annual General Meeting of the Company for the Financial Year 2015-16. 2. Appointment of M/s S. Sarveswara Reddy & Associate, the Practicing Company Secretary, Hyderabad, as Secretarial Auditor for 2015-16. 3. Appointment of M/s S. Sarveswara Reddy & Associate, the Practicing Company Secretary, Hyderabad, as a Scrutinizer for voting in 21st Annual General Meeting. (As per BSE Announcement dated on 29.08.2016)

  • 13-Aug-16

    • Farmax India Ltd has informed BSE that a Meeting of Board of Directors of the Company will be held on August 13, 2016, inter alia, to consider and approve the following: 1. Unaudited Q1 results for the quarter ended June 30, 2016. 2. Limited Review report for the quarter ended June 30, 2016. 3. Closure of Farmax International FZE. In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of August 02, 2016 till day of August 13, 2016 (both days inclusive). Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2016, inter alia, has considered and approved the following : - Closure of Farmax International FZE. (As per BSE Announcement dated on 13.08.2016)

  • 27-May-16

    • Audited Results

  • 21-May-16

    • Farmax India Ltd has informed BSE that the Board Meeting of the Company will be held on May 21, 2016, inter alia, to consider and approve the following: 1. Audited results for the Quarter & Year ended March 31, 2016. 2. Audit Report for the Quarter & Year ended March 31, 2016. In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of May 18, 2016 till day of May 27, 2016 (both days inclusive).

  • 24-Feb-16

    • Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 24, 2016, inter alia, to consider and approve the following: 1. Policy for Determination of Materiality of Events/Information.

AGM
  • 30-Sep-16

    • AGM : 30/09/2016 Farmax India Ltd has informed BSE that the 21st Annual General Meeting (AGM) of the Company will be held on September 30, 2016. (As per BSE Announcement dated on 07.09.2016)

  • 30-Sep-14

    • Farmax India Ltd has informed BSE that the 19th Annual General Meeting (AGM) of the Company was held on September 30, 2014. Farmax India Ltd has informed BSE regarding the details of Voting results at the 19th Annual General Meeting (AGM) of the Company held on September 30, 2014, under Clause 35A. (As Per BSE Announcement dated on 01/10/2014)

  • 29-Jul-13

    • Farmax India Ltd has informed BSE that the 18th Annual General Meeting (AGM) of the Company was held on July 29, 2013.

  • 29-Sep-12

    • Farmax India Ltd has informed BSE that the 17th Annual General Meeting (AGM) of the Company was held on September 29, 2012.

  • 28-Oct-11

    • AGM 28/10/2011 Farmax India Ltd has informed BSE that the members at the 16th Annual General Meeting (AGM) of the Company held on October 28, 2011, inter alia, have transacted the following: 1. Shareholders adopted the Directors' Report, the Audited Profit and Loss Account, the Balance Sheet and Cash Flow statement as at March 31, 2011. 2. Mr. A V Ramaraju who retired by rotation and being eligible, offered himself for re-appointment was re-appointed. 3. M/s. K Prahalda Rao & Co. are appointed as Statutory Auditors of the company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company. 4. Appointment of Mr. Omkareshwar Ganganboina as a Director of the Company. (As Per BSE Announcement Website dated on 28.10.2011)

EGM
  • 24-Jan-15

    • Farmax India Ltd has informed BSE that an Extra-Ordinary General Meeting (EGM) of the Company will be held on January 24, 2015. Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on January 24, 2015. (As Per BSE Announcement dated on 24/01/2015) Farmax India Ltd has submitted to BSE a copy of Revised Outcome of Extra Ordinary General Meeting (EGM) of the Company held on January 24, 2015. (As Per BSE Announcement Dated on 27.01.2015) Farmax India Limited has informed the Exchange that at the Extra-ordinary General Meeting of the Company held on January 24, 2015, the following items were considered and duly approved by the shareholders of the Company. 1) Increase in Authorized Share Capital of the Company. 2) Issue of equity shares to promoters and others on preferential basis. A copy of the consolidated report on e-votng and poll is enclosed. (Clause 35A of the Listing Agreement) (As Per NSE Bulletin Date on 27.01.2015)

  • 08-May-13

    • Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 08, 2013, has approved and considered the following : 1. To lease out the factory premises as per section 293 (1) (a) of the Companies Act, 1956. 2. Appointment of Bhaskara Rao & Associates as Statutory Auditors of the Company for the Financial Year 2012-13. 3. To hold Extra-Ordinary general Meeting on May 08, 2013 to take shareholders approval for item nos. 1 & 2 above. Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 08, 2013. (As per BSE Announcement Dated on 16.04.2013) Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on May 08, 2013. (As Per BSE Announcement Dated on 08.05.2013)

  • 19-Dec-11

    • Farmax India Ltd has informed BSE hat a meeting of the Board of Directors of the Company will be held on February 17, 2012 to review the process or progress of Preferential Allotment initiated in terms of special resolution passed in the EGM held on December 19, 2011.

  • 01-Jan-10

    • Farmax Retail (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2009, inter alia, has considered and approved the following: 1. Increase of Authorized Capital from Rs. 14 Crores to Rs. 50 Crores. 2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. 3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws. 4. Convening EGM of the shareholders on January 01, 2010 for the above matters. Farmax Retail (India) Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on January 01, 2010.inter alia, to transact the following items of business: 1. Increase of Authorized Share Capital: - To increase the Authorized Share Capital of the Company from Rs. 14,00,00,000/- (Rupees Fourteen Crores Only) divided into 1,40,00,000 (One Crore Forty Lakhs) equity shares of Rs. 10/- (Rupees Ten Only) each to Rs. 50,00,00,000/- (Rupees Fifty Crores Only) divided into 5,00,00,000 (Five Crores) equity shares of Rs. 10/- (Rupees Ten Only) each, ranking pari passu with the existing equity shares & consequential amendment in the Memorandum of Association of the Company. 2. Sub-division of the Face Value of Equity Shares: - For sub-division of each of the existing issued equity shares of Rs. 10/- (Rupees Ten Only) each in the issued, subscribed and paid-up capital of the Company into 2 (Two) equity shares of the face value of Rs. 5/- (Rupees Five Only) each fully paid up consequential amendment in the Memorandum and Articles of Association pertaining to the Share Capital of the Company be accordingly altered. 3. To raise monies on preferential basis: - To offer, issue and allot (including with provisions for reservation on firm and / or competitive basis, of such part of issue and for such categories of persons including employees of the Company as may be permitted) either in India or in the course of international offering(s) in one or more foreign markers, such number of Equity Shares with or without a green shoe option. Global Depository Receipts (GDRs), in registered or bearer form, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (as defined by the SEBI (DIP) Guidelines, 2000) pursuant to a Qualified Institutions Placements, as provided under Chapter XIIIA of the SEBI DIP Guidelines (QIP) and / or securities with or without detachable warrants with right exercisable by the warrant holders to convert or subscribe to Equity Shares (all of which are hereinafter collectively referred to as Securities) or any combination of Securities, in one or more tranches, whether rupee denominated or denominated in foreign currency, to any eligible person, including foreign / resident invertors (whether institutions, incorporated bodies, mutual funds, individuals or otherwise), Foreign Institutional Investors, Indian and / or Multilateral Financial Institutions, Mutual Funds, Non-Resident Indians, stabilizing agents, and / or any other categories of investors, whether they be holders of shares of the Company or not (collectively called the Investors) through public issue(s) of prospectus in India or outside India, a qualified institutional placement, a rights offering, private placements(s) in India or outside India, or a combination thereof at such time or times, at such price or prices, at a discount or premium to market price or prices in such manner and on such terms and conditions as may be deemed appropriate by the Board at its absolute discretion including the discretion to determine the categories of Investors to whom the offer, issue and allotment shall be made to the exclusion of all other categories of Investors at the time of such offer, issue and allotment considering the prevailing market conditions and other relevant factors and wherever necessary in consultation with Lead Managers, up to an amount not exceeding Rs. 500 Crores (Rupees Five Hundred Crores Only) either in foreign currency or Indian Rupees inclusive of such premium as may be determined by the Board, in any convertible foreign currency, as the Board at its absolute discretion may deem fit and appropriate, subject to necessary provisions & approvals. (As Per BSE Announcement Dated on 30/12/2009) Farmax Retail (India) Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 01, 2010, inter alia, have approved the following: 1. Increase ofAuthorized Capital from Rs. 14 Crores to Rs. 50 Crores. 2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. 3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws. (As Per BSE Announcement Dated on 04/01/2010)

Futures & Options Quote
Future Data Not present
Key Information

Key Executives:

M Srinivasa Reddy , Chairman & Managing Director

A V Rama Raju , Independent Director

P Priyanka , Independent Director

Sudheer Reddy , Independent Director


Company Head Office / Quarters:

Survey No 658 Bowrampet Villag,
Qutubullapur Mandal,
Ranga Reddy,
Telangana-500043
Phone : Telangana- / Telangana-
Fax : Telangana-91-08418-23065762 / Telangana-
E-mail : cs@farmax.co.in
Web : http://www.farmax.co.in

Registrars:

Big Share Services Pvt Ltd
3rd Flr 306 Rightwin,Amrutha Ville,Somajiguda,Hyderabad-500082

 
Fund Holding
Scheme Name No. of Shares
 
Calendar
Mon Tue Wed Thu Fri Sat Sun
08 09 10 11 12 13 14